Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
104
datasets available to search
ShareScore release 0.9.0
Dataset results
104 results for “Ifosfamide”
Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment
ClinicalTrials.gov study NCT02812654. IPD Sharing: UNDECIDED. Countries: 1. Publications: 10.
Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients
ClinicalTrials.gov study NCT01749072. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
ClinicalTrials.gov study NCT00061984. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma
ClinicalTrials.gov study NCT04690231. IPD Sharing: NO. Countries: 1. Publications: 1.
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
ClinicalTrials.gov study NCT00003128. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma
ClinicalTrials.gov study NCT03514381. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
ClinicalTrials.gov study NCT00358540. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma
ClinicalTrials.gov study NCT00001300. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients
ClinicalTrials.gov study NCT03815474. IPD Sharing: NO. Countries: 1. Publications: 2.
Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer
ClinicalTrials.gov study NCT01752517. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
ClinicalTrials.gov study NCT03342300. IPD Sharing: YES. Countries: 1. Publications: 17.
Figure 6 from: AlMotwaa SM (2021) Coupling Ifosfamide to nanoemulsion-based clove oil enhances its toxicity on malignant breast cancer and cervical cancer cells. Pharmacia 68(4): 779-787. https://doi.org/10.3897/pharmacia.68.e68291
Figure 6 Relative fluorescence intensity of nuclei at various concentrations of the studied formulas analyzed using Image J 1.43. Data are expressed as mean ± SE (n=3). Asterisks denote statistical significance (***p < 0.001 considered as very highly significant, **0.001 ≤ p < 0.01 considered as highly significant, and *0.01 ≤p < 0.05 considered as significant).
Figure 5 from: AlMotwaa SM (2021) Coupling Ifosfamide to nanoemulsion-based clove oil enhances its toxicity on malignant breast cancer and cervical cancer cells. Pharmacia 68(4): 779-787. https://doi.org/10.3897/pharmacia.68.e68291
Figure 5 Fluorescence microscopic images of changes in nuclear morphology of MCF-7 cells treated with various concentrations of the tested formulas for 24h, as revealed using DAPI stain (n = 3).
Figure 4 from: AlMotwaa SM (2021) Coupling Ifosfamide to nanoemulsion-based clove oil enhances its toxicity on malignant breast cancer and cervical cancer cells. Pharmacia 68(4): 779-787. https://doi.org/10.3897/pharmacia.68.e68291
Figure 4 Fluorescence microscopic images of changes in nuclear morphology of HeLa cells treated with various concentrations of the tested formulas for 24h, as revealed using DAPI stain (n = 3).
Figure 2 from: AlMotwaa SM (2021) Coupling Ifosfamide to nanoemulsion-based clove oil enhances its toxicity on malignant breast cancer and cervical cancer cells. Pharmacia 68(4): 779-787. https://doi.org/10.3897/pharmacia.68.e68291
Figure 2 Cell viability of HeLa and MCF-7 cells after 24h of incubation with clove oil-based NE at various concentrations. Data are expressed as mean ± SE (n = 3). Asterisks denote statistical significance (***p < 0.001 considered as very highly significant, **0.001 ≤ p < 0.01 considered as highly significant, and *0.01 ≤ p < 0.05 considered as significant).
Figure 3 from: AlMotwaa SM (2021) Coupling Ifosfamide to nanoemulsion-based clove oil enhances its toxicity on malignant breast cancer and cervical cancer cells. Pharmacia 68(4): 779-787. https://doi.org/10.3897/pharmacia.68.e68291
Figure 3 Photomicrographs of cellular morphologies at IC50 after 24 h incubation (n=3). The arrows colored brown, green, red, black, and dark red indicate membrane blebbing, cytoplasmic vesicles, enlarged nuclei, loss of membrane integrity, and extracellular vesicles, respectively.
Figure 1 from: AlMotwaa SM (2021) Coupling Ifosfamide to nanoemulsion-based clove oil enhances its toxicity on malignant breast cancer and cervical cancer cells. Pharmacia 68(4): 779-787. https://doi.org/10.3897/pharmacia.68.e68291
Figure 1 Preparation and characterization of clove oil-based NE. A preparation of formulated NEsB, C Z-average diameter (n=3); D, E Zeta potential for n=3 using Zetasizer Malvern, UK). Asterisks denote statistical significance (**0.001 ≤ p < 0.01 considered as highly significant, and *0.01 ≤ p < 0.05 considered as significant).
A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma
ClinicalTrials.gov study NCT03283696. IPD Sharing: NO. Countries: 3. Publications: 0.
Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery
ClinicalTrials.gov study NCT00880542. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin
ClinicalTrials.gov study NCT00423852. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.